Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Purchase of Sistema Bank cost Samolet ₽1.5 billion

4/26/24 SMLT

Unipro's output in Q1 decreased by 0.5%

4/26/24 UPRO

Fix Price's LFL sales in Q1 started to improve

4/26/24 FIXP

Artgen reported for 2023 by IFRS

4/26/24 ABIO

Fix Price reported for 3 months of 2024 by IFRS

4/26/24 FIXP

Mordoaenergosbyt reported for 3 months of 2024 by RAS

4/26/24 MRSB

Rosseti Center and Volga Region reported for 3 months of 2024 by RAS

4/26/24 MRKP

Rosseti Center reported for 3 months of 2023 by RAS

4/26/24 MRKC

Sberbank reported for 3 months of 2024 by IFRS

4/26/24 SBER

X5 Retail Group bought Nais Ice ready-to-eat food production facility

4/26/24 X5